Business Context and Reporting Period
Company: Prestige Brands Holdings, Inc. (Prestige Consumer Healthcare Inc.)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three and six months ended September 30, 2008
Business Overview: The Company markets, sells, and distributes over-the-counter healthcare, personal care, and household cleaning brands to mass merchandisers, drug stores, and supermarkets primarily in the U.S. and Canada. Operations are divided into three segments: Over-the-Counter (OTC) Healthcare, Household Cleaning, and Personal Care.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2008 |
Three Months Ended Sep 30, 2007 |
Six Months Ended Sep 30, 2008 |
Six Months Ended Sep 30, 2007 |
|---|---|---|---|---|
| Total Revenues | $88,051 | $87,337 | $161,585 | $165,948 |
| Gross Profit | $46,259 | $44,567 | $85,521 | $85,856 |
| Gross Margin % | 52.5% | 51.0% | 52.9% | 51.7% |
| Operating Income | $20,501 | $20,610 | $41,715 | $43,716 |
| Net Income | $8,522 | $6,829 | $16,303 | $15,149 |
| Diluted EPS | $0.17 | $0.14 | $0.33 | $0.30 |
| Net Cash from Operating Activities | N/A | N/A | $36,676 | $21,492 |
| Total Debt (Long-term + Current) | $385,225 | N/A | $385,225 | N/A |
| Cash and Cash Equivalents | $12,630 | N/A | $12,630 | N/A |
Material Changes vs. Prior Period
- Revenue Trends: For the three months ended September 30, 2008, revenues increased 0.8% year-over-year. However, for the six-month period, revenues decreased 2.6% to $161.6 million. The decline in the six-month period was driven by decreases across all segments, particularly Personal Care (-11.3%) and OTC Healthcare (-3.1%).
- Profitability: Net income increased 24.8% for the quarter ($8.5M vs $6.8M) and 7.6% for the six-month period ($16.3M vs $15.1M). This improvement occurred despite revenue declines in the six-month view, primarily due to reduced interest expense and the absence of costs related to a voluntary product recall in the prior year.
- Segment Performance:
- OTC Healthcare: Revenue growth in the quarter was driven by the launch of "Allergen Block" products and distribution gains for "Little Remedies," offsetting declines in wart care brands due to price reductions.
- Household Cleaning: Revenue increased 2.3% in the quarter, led by "Comet Mildew Spray Gel," though gross profit margins compressed due to higher product and distribution costs.
- Personal Care: Revenue declined 5.8% in the quarter and 11.3% over six months, with declines across major brands like Cutex, Prell, and Denorex.
- Interest Expense: Net interest expense decreased significantly to $6.8 million for the quarter (from $9.8 million) and $15.5 million for six months (from $19.3 million). This was due to lower average indebtedness ($392.6M vs $437.8M) and lower interest rates (6.9% vs 8.7%).
- Working Capital: Cash provided by operating activities for the six months increased to $36.7 million from $21.5 million, largely due to a decrease in accounts receivable compared to the prior year.
Guidance, Outlook, Risks, and Contingencies
- Liquidity Strategy: Management intends to build cash reserves to approximately $30.0 million to enhance liquidity given the current economic environment and credit market uncertainties. Consequently, the Company expects to make only modest debt repayments through March 31, 2009, resuming aggressive repayments once the reserve target is met.
- Debt Maturity: The Revolving Credit Facility ($60M capacity) expires in April 2009, and the Tranche B Term Loan Facility ($259.2M outstanding) matures in April 2011. Management intends to replace these facilities but notes that credit market conditions could impede refinancing on favorable terms.
- Legal Proceedings:
- Securities Class Action: A consolidated class action regarding the 2005 IPO remains pending. The Company believes claims are legally deficient but cannot estimate potential loss.
- DenTek Litigation: The Company is involved in intellectual property litigation against DenTek Oral Care, Inc. and former employees. While some claims were dismissed, others remain, and defendants have filed counterclaims. The Company cannot estimate potential loss.
- Risk Factors: Key risks include dependence on a limited number of customers (one customer accounted for 25.7% of sales in the six-month period), reliance on third-party manufacturers (top 10 account for 75% of sales), and potential impairment of goodwill and intangible assets which comprise the majority of the Company's assets.
Investor Verification Checklist
- Debt Refinancing: Verify the Company's ability to refinance the $60M revolving credit facility expiring in April 2009 and the $259M term loan maturing in 2011 amidst tight credit markets.
- Customer Concentration: Assess the risk associated with one customer representing approximately 25% of total sales and 21% of accounts receivable.
- Intangible Asset Valuation: Review the valuation of goodwill and intangible assets ($951.3M total), which represent the vast majority of the balance sheet, for potential impairment triggers given revenue declines in certain segments.
- Legal Exposure: Monitor the status of the securities class action and DenTek litigation for any settlement developments or adverse rulings.
- Product Mix Shifts: Evaluate the sustainability of revenue growth in the OTC segment driven by new product launches (Allergen Block) versus declines in legacy brands (Compound W, Cutex).